20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Charles River Laboratories (CRL) operates in the Life Sciences Tools & Services industry and is headquartered in Wilmington, United States with about 18,300 employees. Its market capitalization is roughly $13 billion. In the fiscal year ended 2025-12-31, CRL reported $4.0B in revenue and ($144M) in net income.
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally.
Interactive charts & full statements → Open the CRL valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $4.0B | $4.0B | $4.0B | $4.1B | $4.0B | $3.5B | $2.9B | $2.6B | $2.3B | $1.9B | $1.7B | $1.4B | $1.3B | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B | $1.3B | $1.2B | $1.1B |
| Gross Profit | $1.3B | $1.2B | $1.3B | $1.5B | $1.5B | $1.3B | $1.1B | $958M | $840M | $701M | $644M | $531M | $473M | $395M | $392M | $402M | $385M | $423M | $511M | $478M | $407M |
| Gross Margin % | 32.2% | 30.5% | 32.9% | 36.4% | 36.8% | 37.7% | 36.7% | 36.6% | 37.1% | 37.7% | 38.3% | 39.0% | 36.4% | 33.9% | 34.7% | 35.2% | 34.0% | 35.2% | 38.0% | 38.9% | 38.4% |
| Operating Income (EBIT) | $494M | $508M | $227M | $617M | $651M | $590M | $433M | $351M | $331M | $288M | $238M | $206M | $178M | $151M | $166M | $174M | ($299M) | $170M | ($450M) | $227M | $188M |
| Operating Margin % | 12.3% | 12.7% | 5.6% | 14.9% | 16.4% | 16.7% | 14.8% | 13.4% | 14.6% | 15.5% | 14.1% | 15.1% | 13.7% | 13.0% | 14.7% | 15.2% | -26.3% | 14.1% | -33.5% | 18.5% | 17.8% |
| Net Income | ($240M) | ($144M) | $10M | $475M | $486M | $391M | $364M | $252M | $226M | $123M | $155M | $149M | $127M | $103M | $97M | $110M | ($337M) | $114M | ($522M) | $154M | ($56M) |
| Net Margin % | -6.0% | -3.6% | 0.2% | 11.5% | 12.2% | 11.0% | 12.5% | 9.6% | 10.0% | 6.6% | 9.2% | 10.9% | 9.8% | 8.8% | 8.6% | 9.6% | -29.7% | 9.5% | -38.8% | 12.6% | -5.3% |
| EBITDA | — | $411M | $581M | $1.0B | $986M | $820M | $768M | $563M | $507M | $458M | $377M | $305M | $286M | $256M | $244M | $260M | ($205M) | $263M | ($356M) | $322M | $273M |
| Earnings Per Share (EPS) | $-4.85 | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 | $2.12 | $2.01 | $2.14 | $-5.38 | $1.74 | $-7.76 | $2.25 | $-0.80 |
| Shares Outstanding (M) | — | 50M | 52M | 51M | 51M | 51M | 51M | 50M | 49M | 49M | 48M | 48M | 48M | 48M | 48M | 51M | 63M | 66M | 67M | 69M | 70M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.0B | $996M | $994M | $1.0B | $1.0B | $984M | $1.0B | $1.0B | $1.0B |
| Gross Profit | $363M | $279M | $308M | $339M | $357M | $318M | $284M | $349M | $354M |
| Gross Margin % | 36.2% | 28.1% | 31.0% | 33.7% | 34.6% | 32.3% | 28.3% | 34.6% | 34.5% |
| Operating Income (EBIT) | $120M | $120M | $120M | $134M | $100M | $75M | ($168M) | $117M | $152M |
| Operating Margin % | 11.9% | 12.0% | 12.1% | 13.3% | 9.7% | 7.6% | -16.7% | 11.6% | 14.8% |
| Net Income | ($2M) | ($15M) | ($277M) | $54M | $52M | $25M | ($216M) | $69M | $90M |
| Net Margin % | -0.2% | -1.5% | -27.8% | 5.4% | 5.1% | 2.6% | -21.5% | 6.8% | 8.8% |
| EBITDA | — | $64M | ($192M) | $198M | $221M | $184M | ($86M) | $210M | $239M |
| Earnings Per Share (EPS) | $-0.03 | $-0.30 | $-5.62 | $1.10 | $1.06 | $0.50 | $-4.22 | $1.33 | $1.74 |
| Shares Outstanding (M) | — | 49M | 49M | 49M | 49M | 51M | 51M | 52M | 52M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $583M | $738M | $735M | $684M | $620M | $761M | $547M | $481M | $441M | $316M | $298M | $286M | $251M | $207M | $208M | $205M | $169M | $225M | $280M | $284M | $164M |
| Capital Expenditures (CapEx) | $212M | $219M | $233M | $319M | $325M | $229M | $167M | $141M | $140M | $82M | $55M | $63M | $57M | $39M | $48M | $49M | $43M | $80M | $197M | $227M | $182M |
| Free Cash Flow (FCF) | $371M | $518M | $502M | $365M | $295M | $532M | $380M | $340M | $301M | $234M | $243M | $223M | $194M | $168M | $160M | $156M | $126M | $145M | $83M | $57M | ($17M) |
| FCF Margin % | 9.3% | 12.9% | 12.4% | 8.8% | 7.4% | 15.0% | 13.0% | 13.0% | 13.3% | 12.6% | 14.4% | 16.4% | 15.0% | 14.4% | 14.2% | 13.7% | 11.1% | 12.1% | 6.2% | 4.7% | -1.6% |
| Dividends Paid | — | — | — | $26M | — | $46M | $47M | $35M | — | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | — | — | $2M | $2M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $180M | $41M | $148M | $214M | $205M | $172M | $159M | $252M | $194M |
| Capital Expenditures (CapEx) | $31M | $56M | $89M | $36M | $35M | $59M | $76M | $39M | $39M |
| Free Cash Flow (FCF) | $149M | ($15M) | $59M | $178M | $169M | $112M | $84M | $213M | $154M |
| FCF Margin % | 14.8% | -1.5% | 5.9% | 17.7% | 16.4% | 11.4% | 8.3% | 21.1% | 15.0% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.5B | $7.1B | $7.5B | $8.2B | $7.6B | $7.0B | $5.5B | $4.7B | $3.9B | $2.9B | $2.7B | $2.1B | $1.9B | $1.6B | $1.6B | $1.6B | $1.7B | $2.2B | $2.2B | $2.8B | $2.6B |
| Cash & Cash Equivalents | $192M | $214M | $195M | $277M | $234M | $245M | $228M | $238M | $195M | $164M | $118M | $118M | $160M | $156M | $110M | $69M | $179M | $183M | $244M | $225M | $175M |
| Total Liabilities | $4.6B | $3.9B | $4.0B | $4.5B | $4.6B | $4.4B | $3.3B | $3.0B | $2.5B | $1.9B | $1.9B | $1.3B | $1.2B | $980M | $983M | $1.0B | $1.0B | $830M | $960M | $942M | $953M |
| Total Debt (Short + Long-Term) | $3.0B | $2.2B | $2.4B | $3.1B | $2.8B | $2.7B | $2.0B | $1.9B | $1.7B | $1.1B | $1.2B | $863M | $778M | $664M | $667M | $718M | $701M | $508M | $576M | $510M | $572M |
| Total Shareholders' Equity | $2.8B | $3.2B | $3.5B | $3.6B | $3.0B | $2.5B | $2.1B | $1.6B | $1.3B | $1.0B | $837M | $733M | $672M | $641M | $601M | $527M | $687M | $1.4B | $1.2B | $1.9B | $1.6B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CRL viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms